Screening for Preeclampsia With Various Markers in Low-risk Pregnancy Populations
NCT01649128 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 262
Last updated 2012-07-25
Summary
For the prediction of late-onset preeclampsia (PE) in low risk women, the investigators established a cut-off value for sFlt-1/PlGF ratio and evaluated the combination models of Elecys, second trimester uterine artery (UtA) doppler, and fetoplacental proteins for Down syndrome screening.
Conditions
Sponsors & Collaborators
-
CHA University
lead OTHER
Eligibility
- Min Age
- 20 Years
- Max Age
- 39 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-08-31
- Primary Completion
- 2011-12-31
- Completion
- 2011-12-31
More Related Trials
-
Early Placental Insufficiency Screening
NCT01348711 ·Status: TERMINATED
-
Prediction of Preeclampsia by Comprehensive Markers.
NCT03665623 ·Status: COMPLETED
-
Doppler and Biological Second Trimester Placental Insufficiency Screening
NCT00465634 ·Status: COMPLETED
-
Predicting Late-onset Preeclampsia at 10-14 Weeks of Pregnancy
NCT04075708 ·Status: COMPLETED
-
Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers
NCT02808494 ·Status: COMPLETED
-
Perinatal Outcomes in Patients With Elevated sFlt-1/PlGF Ratio
NCT06403722 ·Status: COMPLETED
-
MorbiMortality Amelioration in Preeclamptic Primiparas Study. MoMA Pre Prim Study
NCT00763672 ·Status: COMPLETED ·Phase: NA
-
Pulmonary Embolism in Pregnancy: Biomarkers and Clinical Predictive Models
NCT02709174 ·Status: COMPLETED
-
Prediction and Prevention of Preeclampsia by First Trimester Ultrasound
NCT01195441 ·Status: COMPLETED
-
Preeclampsia Risk Assessment: Evaluation of Cut-offs to Improve Stratification
NCT03815110 ·Status: COMPLETED
-
Association Between Pococyturia and Pre-eclampsia Severity
NCT03316391 ·Status: COMPLETED
-
Continuous Non-invasive Hemodynamic Monitoring in Early-onset Severe Preeclampsia: a Comparison of Echocardiography, Bioreactance, and Finger Cuff Measurements
NCT05299229 ·Status: COMPLETED
-
Serpin C and Soluble Fms-like Tyrosine Kinase-1 Levels in Normotensive Pregnant Women May Predict the Development of Preeclampsia
NCT06214702 ·Status: COMPLETED
-
Observational Study in UTERO - Placental 3D Doppler Examination: Interest for Pre-eclampsia Screening During Pregnancy
NCT00930397 ·Status: COMPLETED
-
PREPARE, Prematurity Reduction by Pre-eclampsia Care
NCT03073317 ·Status: COMPLETED ·Phase: NA
-
Screening for Intrapartum Fetal Compromise Using Placental Biomarkers
NCT07258329 ·Status: RECRUITING
-
Podocyturia as Predictive Factor for Pre-eclampsia
NCT03316430 ·Status: COMPLETED
-
Detecting Early Onset Pre-eclampsia and Use of Placental Growth Factor (PlGF) for Marker of Trisomy 21
NCT01387776 ·Status: TERMINATED
-
Prediction of Chronic Kidney Disease Following Pre-eclampsia: Diagnosis and Early Care
NCT05056701 ·Status: RECRUITING ·Phase: NA
-
Vascular Biomarkers Predictive of the Progression From Hypertensive Disorders in Pregnancy to Preeclampsia in Pregnant Women
NCT04520048 ·Status: RECRUITING ·Phase: NA
-
Precision Medicine for Prediction & Prevention of Early Pre-eclampsia
NCT04412681 ·Status: UNKNOWN ·Phase: NA
-
Kidney Injury Biomarkers in Preeclampsia
NCT03217916 ·Status: UNKNOWN
-
Impact of the sFlt-1/PlGF Ratio on Medical Decision-making and on Maternal and Neonatal Outcomes in Women Suspected of Preeclampsia
NCT06314555 ·Status: COMPLETED
-
Predictive Value of SFlt-1/PlGF Ratio for the Diagnosis of Cardiovascular Disorders in the Puerperium: Pilot Study
NCT06720857 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Point-of-care Ultrasound Abnormalities in Early Onset Preeclampsia
NCT05662995 ·Status: UNKNOWN ·Phase: NA